Company: PTHS
Filing Date: 2025-11-25
Form Type: DEF 14A
Source: 0001753926-25-001827
Chunk: 2

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-25
Form: DEF 14A
Chunk 2
---
MENT FOR ANNUAL MEETING OF SHAREHOLDERS</div>

In this proxy statement (“Proxy Statement”), Pelthos Therapeutics Inc., a Nevada corporation, is referred to as the “Company,” “we,” “us” and “our.”

Information Concerning the Proxy Materials and the Annual Meeting

Proxies in the form enclosed with this Proxy Statement are being solicited by our Board (the “Board”) for use at our Annual Meeting of Shareholders (the “Annual Meeting”) to be held online on December 17, 2025 at 9:00 am Eastern Time. Your vote is very important. For this reason, the Board is requesting that you permit your shares of common stock, par value $0.0001 per share (the “Common Stock”), to be represented at the Annual Meeting by the proxies named on the enclosed proxy card. This Proxy Statement contains important information for you to consider when deciding how to vote on the matters brought before the Annual Meeting. Please read it carefully.

Voting materials, which include this
Proxy Statement and the enclosed proxy card, will be first mailed to shareholders on or about November 25, 2025. Voting materials,
which include this Proxy Statement and the enclosed proxy card, and our Annual Report on Form 10-K for the year ended December 31,
2024, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 27, 2025, are available at www.proxyvote.com.
Only shareholders of record of our shares of Common Stock as of the close of business on November 24, 2025 (the “Record
Date”) will be entitled to notice of, and to vote at, the Annual Meeting. As of the Record Date, 3,086,681 shares of Common
Stock were issued and outstanding. Shareholders may vote and submit proxy via the internet, by phone, or by signing, dating and
returning a proxy card; however, granting a proxy does not in any way affect a shareholder’s right to attend the Annual
Meeting and vote. Any shareholder giving a proxy has the right to revoke that proxy by (i) filing a later-dated proxy or a written
notice of revocation via internet at any time before the original proxy is exercised or (ii) attending the Annual Meeting via
internet and voting.

Francis Knuettel II and Scott Plesha are named as attorneys-in-fact in the proxy. Mr. Knuettel is our Chief Financial Officer,